publication venue for
- NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development. 9:35378-35393. 2018
- Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells. 9:15895-15914. 2018
- E6AP promotes prostate cancer by reducing p27 expression. 8:42939-42948. 2017
- Insights into the role and regulation of TCTP in skeletal muscle. 8:18754-18772. 2017
- LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness. 8:83626-83636. 2017
- Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study. 8:51522-51529. 2017
- Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer. 8:74036-74048. 2017
- The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma. 8:18640-18656. 2017
- [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo. 8:72260-72271. 2017
- Altered phenotypic and functional characteristics of CD3(+)CD56(+) NKT-like cells in human gastric cancer. 7:55222-55230. 2016
- Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer. 7:85437-85449. 2016
- Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies. 7:66569-66585. 2016
- Copper as a target for prostate cancer therapeutics: Copper-ionophore pharmacology and altering systemic copper distribution. 7:37064-37080. 2016
- Human beta-defensin 3 contains an oncolytic motif that binds PI(4,5)P-2 to mediate tumour cell permeabilisation. 7:2054-2069. 2016
- IAP antagonists sensitize murine osteosarcoma cells to killing by TNF alpha. 7:33866-33886. 2016
- Identifying and targeting determinants of melanoma cellular invasion. 7:41186-41202. 2016
- Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells. 7:19709-19722. 2016
- Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation. 7:16070-16089. 2016
- Systematic identification of immunodominant CD4(+) T cell responses to HpaA in Helicobacter pylori infected individuals. 7:54380-54391. 2016
- Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer. 6:27008-27022. 2015
- Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity. 6:604-616. 2015
- Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells. 6:15752-15771. 2015
- Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin. 6:11175-11190. 2015
- Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles. 6:11327-11341. 2015
- Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways. 6:38166-38180. 2015
- Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion. 6:15953-15965. 2015
- Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes. 6:15375-15396. 2015
- Saikosaponin a inhibits influenza A virus replication and lung immunopathology. 6:42541-42556. 2015
- Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma. 6:1115-1127. 2015
- YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment. 6:13718-13730. 2015
- Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan. 5:2807-2819. 2014
- FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.. 5:264-276. 2014
- Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine. 5:2107-2115. 2014
- Rad51 supports triple negative breast cancer metastasis. 5:3261-3272. 2014
- Role of p53 in the progression of gastric cancer. 5:12016-12026. 2014
- Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma. 5:5782-5797. 2014
- Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase. 3:546-558. 2012
- Methylation profiling of normal individuals reveals mosaic: Promoter methylation of cancer-associated genes. 3:450-461. 2012
- MiRNAs Prognostic for Basal and BRCA1 Breast Cancer 2018
- Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways 2016
- Targeting IL-11 signaling in colon cancer. 4:1860-1861. 2013